1. Home
  2. OSK vs SYRE Comparison

OSK vs SYRE Comparison

Compare OSK & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oshkosh Corporation

OSK

Oshkosh Corporation

HOLD

Current Price

$157.91

Market Cap

9.4B

ML Signal

HOLD

Logo Spyre Therapeutics Inc.

SYRE

Spyre Therapeutics Inc.

HOLD

Current Price

$93.69

Market Cap

8.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OSK
SYRE
Founded
1917
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.4B
8.5B
IPO Year
2009
2015

Fundamental Metrics

Financial Performance
Metric
OSK
SYRE
Price
$157.91
$93.69
Analyst Decision
Buy
Strong Buy
Analyst Count
14
12
Target Price
$166.79
$85.08
AVG Volume (30 Days)
734.0K
795.7K
Earning Date
05-08-2026
05-08-2026
Dividend Yield
1.55%
N/A
EPS Growth
N/A
N/A
EPS
1.14
N/A
Revenue
$7,705,500,000.00
N/A
Revenue This Year
$5.94
N/A
Revenue Next Year
$7.19
N/A
P/E Ratio
$136.17
N/A
Revenue Growth
12.83
N/A
52 Week Low
$116.77
$14.51
52 Week High
$180.49
$110.18

Technical Indicators

Market Signals
Indicator
OSK
SYRE
Relative Strength Index (RSI) 58.79 38.06
Support Level $138.41 $66.78
Resistance Level $158.91 $106.10
Average True Range (ATR) 4.41 4.57
MACD 0.10 -1.11
Stochastic Oscillator 82.40 12.26

Price Performance

Historical Comparison
OSK
SYRE

About OSK Oshkosh Corporation

Oshkosh is a leading maker of access equipment, specialty vehicles, and military trucks. It serves diverse end markets, including postal, firefighting, refuse/recycling collection, aviation, and construction. It is typically the market share leader or No. 2 player in North America, or even the global leader in the case of its JLG aerial work platform business. The transport segment is a leading provider of light trucks to the military and vehicles to the Postal Service. The vocational segment, featuring brands such as Pierce, AeroTech, and Volterra, offers purpose-built vehicles and equipment to municipalities. The company reports three segments—Access equipment (45% of revenue), Vocational (35%), and Transport (20%) on 2025 revenue of $10.4 billion.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (IBD) and rheumatic diseases. Spyre's pipeline includes extended half-life antibodies targeting α4β7, TL1A, and IL-23 in development as monotherapies and pair-wise combinations. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Share on Social Networks: